RT Journal
A1 Campbell EG, Pham-Kanter G, Vogeli C, Iezzoni LI
T1 Physician acquiescence to patient demands for brand-name drugs: Results of a national survey of physicians
JF JAMA Internal Medicine
JO JAMA Internal Medicine
YR 2013
FD February 11
VO 173
IS 3
SP 237
OP 239
DO 10.1001/jamainternmed.2013.1539
UL http://dx.doi.org/10.1001/jamainternmed.2013.1539
AB 
Prescribing brand-name drugs when generic drugs are available generates unnecessary medical expenditures, the costs of which are borne by the public in the form of higher copayments, increased health insurance costs, and higher Medicare and Medicaid expenses.1- 2 Pharmaceutical companies aim to stimulate patients' requests for brand-name medications and increase the likelihood physicians will honor such requests.3- 4 Presently, little is known about how frequently physicians comply with such a request or the factors predicting this behavior.